Filana Therapeutics (FLNA) traded down -4.69 % during a 24 hours period ending at 01:15 PM Central Europe on Tuesday 27th. One Filana Therapeutics stock can currently be bought for about USD 0.61 on popular exchanges. Current supply of Filana Therapeutics stocks is 48.3 mn. Filana Therapeutics has a current market capitalization of USD 30.4 mn and approximately USD 181.2 k worth of Filana Therapeutics was traded on exchanges in the last 24 hours. Since last month end, Filana Therapeutics has traded -28.24 % down. Simple moving average of last 200 days is at USD 1.39. The highest price of past 52 weeks was recorded at USD 3.56 on 10/29/2025. 52 weeks low was at USD 0.6 on 10/26/2026.
Here is how related stocks have performed in the past 24 hours:
Biote (BTMD) traded up 7.48 % and now trades at USD 1.15. Biote has a market capitalisation of USD 36.3 mn.
Precipio (PRPO) traded down -3.3 % and now trades at USD 19.35. Current market capitalisation for Precipio is USD 35.8 mn.
Omni-lite Industries Canada (OLNCF) traded down -0.45 % and now trades at USD 2.28. Omni-lite Industries Canada has a market capitalisation of USD 36.3 mn. Omni-lite Industries Canada has a current price to earnings ratio of 28.99.
Star Equity (STRR) traded up 1.96 % and now trades at USD 9.89. Current market capitalisation for Star Equity is USD 35.8 mn.
Cryo-cell (CCEL) traded up 12.33 % and now trades at USD 5.01. Current market capitalisation for Cryo-cell is USD 35.9 mn.
About Filana Therapeutics
Cassava Sciences, Inc. is a clinical-stage biotechnology company based in Austin, Texas, United States. The company specializes in detecting and treating neurodegenerative diseases such as Alzheimer’s. Cassava Sciences serves clients in the United States and can be accessed through their website at www.cassavasciences.com . The company went public on the Nasdaq stock exchange on July 14, 2000.
